In its “Draft Guidance for Industry on Safety Considerations for Container Labels and Carton Labelling Design to Minimize Medication Errors”1 the US FDA recommends the use of a transferable or peel-off label for the commercial container of injectable products. This type of label can help minimize the use of unlabelled syringes because the label would be attached to the commercial container closure, present at the point of product preparation, and not be discarded as in the case with other auxiliary labels often provided with the carton. This is based upon the observations by the FDA that “once an injectable medication is withdrawn from the commercial container closure (e.g. vial or ampoule) into a syringe for administration, the syringe no longer provides information needed by the end user to verify the drug name and strength prior to administration. Such unlabelled medication has led to administration of the wrong drug and wrong strength."
hameln’s Ready-to-Use 50 ml vials will now start to be supplied with enhanced Integrated Syringe Labels (ISL). The labels are designed in such a way that the approved information of the upper label will always remain on the vial and only the ISL can be removed from the vial for attaching to the syringe.
The labels also incorporate design features as recommended by the Royal College of Anaesthetists Syringe Labelling in Critical Care Areas Review 20142.
The integrated syringe label can be applied in four simple steps:
Step 1: remove the upper label and turn it aside. The upper label remains attached to the vial
Step 2: remove the second label (syringe label) from the vial
Step 3: fix the syringe label onto the syringe
Step 4: draw up the solution once the syringe is labelled
hameln is a leading supplier of high quality generic injectable medicines, specialising in critical care. Our portfolio contains a variety of products, ranging from water for injections to sedatives, anaesthetics, analgesics and antidotes. Everything we do is driven by the understanding we are all patients.